coronavirusScienceCovid Vaccines in Phase III, New Risk Calculators, and MoreBy Eve SneiderScienceWhy Is It So Hard to Study Covid-Related Smell Loss?By Sara HarrisonCultureCovid-19 Support Groups Are a Potential Research Gold MineBy Emma Grey EllisIdeasCovid-19 Vaccines Could End Up With Bias Built Right InBy Roxanne KhamsiCultureIf You're Dating Online in a Pandemic, Ghost or Be GhostedBy Elena LaceyScienceCould a Century-Old TB Shot Protect Against Other Diseases?By Gayathri VaidyanathanScienceColds Nearly Vanished Under Lockdown. Now They’re Coming BackBy Gregory BarberScienceThe 943-Dimensional Chess of a Trustworthy Covid-19 VaccineBy Adam RogersScienceThe NIH Launches a Global Hunt for Animal-to-Human DiseasesBy Maryn McKennaBusinessA Utah Company Claims It Invented Contact Tracing TechBy Gregory BarberScienceAmerica’s Top Science Journal Has Had It With TrumpBy Adam RogersScienceIf You've Just Had Covid, Exercise Might Not Be Good for YouBy Megan MolteniScienceCould Breathalyzers Make Covid Testing Quicker and Easier?By Keith GilloglyScienceAsbestos Removal Is a Hard Job, but Covid-19 Makes It HarderBy Sofia Quaglia ScienceHow Does a Sturgis-Sized Crowd Affect Covid? It's ComplicatedBy Megan MolteniScienceBlood Centers Are Barely Meeting Convalescent Plasma DemandBy Sara HarrisonIdeas44 Square Feet: A School-Reopening Detective StoryBy David ZweigBusinessMeet This Year’s WIRED25: People Who Are Making Things BetterBy Graham HaciaScienceMental Health in the US is Suffering—Will It Go Back to Normal?By Grace HuckinsBusinessWhy Contact-Tracing Apps Haven’t Slowed Covid-19 in the USBy Gregory Barber and Will KnightBusinessDoctors and Nurses Take to TikTok to Fight Covid MythsBy Helen SantoroBusinessBig Tech Companies Want to Help Get You Back in the OfficeBy Tom SimoniteIdeasThe Flagrant Hypocrisy of Bungled College ReopeningsBy C. Brandon OgbunuIdeasNo, Public Trust in Scientific Institutions Has Not ErodedBy Daniel EngberMore Stories
